Onconetix, INC. (ONCO) — 8-K/A Filings

All 8-K/A filings from Onconetix, INC.. Browse 4 Amended Current Event Report reports with AI-powered summaries and risk analysis.

8-K/A Filings (4)

Onconetix Delisted from Nasdaq, Files 8-K/A Amendment — Oct 9, 2024 Risk: high
Onconetix, Inc. filed an amendment (8-K/A) on October 9, 2024, to its Form 8-K dated September 18, 2024. This amendment primarily addresses the company's failur
Onconetix, Inc. Files 8-K/A Amendment on Officer/Director Changes — Jun 14, 2024 Risk: medium
Onconetix, Inc. filed an amendment (8-K/A) on June 14, 2024, to a previous report dated June 10, 2024. The amendment pertains to the departure of directors or c
Onconetix Files Amendment to 8-K — Mar 13, 2024 Risk: low
Onconetix, Inc. filed an amendment (No. 3) to its Form 8-K on March 13, 2024, reporting an event that occurred on December 15, 2023. This amendment pertains to
Onconetix Amends 8-K for Dec 15 Asset Acquisition/Disposition — Feb 27, 2024 Risk: medium
Onconetix, Inc. filed an 8-K/A (Amendment No. 2) on February 27, 2024, pertaining to an event that occurred on December 15, 2023. The filing primarily concerns

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX